March 23, 2020 / 12:59 PM / 12 days ago

BRIEF-On Mar 21, Jaguar Health Submitted Request To U.S. FDA For Emergency Use Authorization For Crofelemer For Symptomatic Relief Of Diarrhea In Patients With COVID-19

March 23 (Reuters) - Jaguar Health Inc:

* JAGUAR HEALTH - ON MAR 21, CO SUBMITTED REQUEST TO U.S. FDA FOR EMERGENCY USE AUTHORIZATION FOR CROFELEMER FOR SYMPTOMATIC RELIEF OF DIARRHEA IN PATIENTS WITH COVID-19 Source: (bit.ly/2UbHA2z) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below